Series medicament of zanthoxylum bungeanum seed kernel oil and pseudo-ginseng total saponin and preparing process thereof

Abstract

The present invention relates to a Chinese medicine preparation for curing angiocardiopathy and cerebrovascular disease, said Chinese medicine can be made into oral liquor, tablet and capsule preparation. Its effective prescription is formed from xanthoxylum seed oil and notoginseng total saponin. Said invented medicine preparation can obtain obvious therapeutic effect, and said invention also provides its preparation method and concrete steps.

Description

Technical field: [0001] The series of medicaments combined with pepper seed germ oil and Panax notoginseng saponins and the preparation process thereof belong to the medicine for treating cardiovascular and cerebrovascular diseases and the preparation process thereof, and especially relate to the compound Chinese medicine preparation and its series of products which are combined with extracts from Chinese medicinal materials Preparation Process. Background technique [0002] The treatment, prevention and drug development of cardiovascular and cerebrovascular diseases represented by hypertension, coronary heart disease and cerebral thrombosis are the focus of the modernization of traditional Chinese medicine at home and abroad. The main Chinese medicinal materials used in traditional medicine are salvia miltiorrhiza, ginkgo, kudzu root, chuanxiong, hair holly, hawthorn , safflower, perilla, seabuckthorn, flax, amaranthus, etc., but the content of its medicinal ingredients is ...

AI Technical Summary

Problems solved by technology

[0002] The treatment, prevention and drug development of cardiovascular and cerebrovascular diseases represented by hypertension, coronary heart disease and cerebral thrombosis are the focus of the modernization of traditional Chinese medicine at home and abroad. The main Chinese medicinal materials used in traditional medicine are salvia miltiorrhiza, ginkgo, kudzu root, chuanxiong, hair holly, hawthorn , safflower, perilla, seabuckthorn, flax, amaranthus, etc., but the content of its medicinal ingredients is low, low curative effect and repeated prescription drug development, especially traditional Chinese patent medicines with more repeated dosage forms, high production costs , the price is expensive, and the economic burden of long-term use is very heavy for patients. Because the treatment range is narrow and the curative effect is not outstanding, it is difficult to adapt to the selection of patients with different cardiovascular and cerebrovascular diseases.

Since it was confirmed that α-linolenic acid can generate EPA (20:5N-3) and DHA (22:6N-3) through dehydrogenation in the human body, domestic and foreign medicinal materials rich in α-linolenic acid, safflower, purple Extracting fatty acid oil from plant seeds such as perilla and seabuckthorn to replace deep-sea fish oil to develop new drugs for treating cardiovascular and cerebrovascular diseases has once become a hot topic, but according to "Modern Research and Clinical Application of Traditional Chinese Medicine" published by Xueyuan Press in October 1993 Relevant information on pages 332, 378 and 633 of the book confirms that safflower extract has obvious mutagenic effect, seabuckthorn oil and total flavonoids of seabuckthorn have strong cumulative toxicity, perilla contains toxic eugenol , α-pinene, and perillyl alcohol, the toxic and side effects have become obstacles to the development of new national traditional Chinese medicines from the effective parts of the above-mentioned Chinese medicinal materials